Mesenchymal stem cells as a vehicle for ion channel transfer in syncytial structures
This invention provides a composition for delivery of a gene to a syncytial structure comprising stem cells incorporated with the gene. This invention also provides a composition for ion channel transfer which comprises stem cells incorporated with a compound in an amount sufficient to create ion channels. This invention also provides for a method of expressing a functional gene product in a syncytial structure comprising administering a composition, comprising stem cells that have been incorporated with a gene, to the syncytial structure. This invention further provides a method of expressing a functional ion channel in a syncytial structure comprising administering a composition, comprising stem cells that have been incorporated with a compound in an amount sufficient to create ion channels, to the syncytial structure. This invention also provides a composition for delivery of small molecules comprising stem cells incorporated with the small molecules or genes encoding the small molecules.
1. A composition for delivery to a mammalian heart comprising an isolated mesenchymal stem cell incorporated with a nucleic acid encoding at least one hyperpolarization-activated, cyclic nucleotide-gated (HCN) channel, the HCN-encoding region being functionally linked to a promoter, wherein the nucleic acid encoding the at least one HCN channel is expressed, wherein the mesenchymal stem cell further comprises a nucleic acid molecule encoding a MiRP1 polypeptide.
2. A method of expressing at least one pacemaker ion channel in a mammalian heart, wherein the at least one pacemaker ion channel is a hyperpolarization-activated, cyclic nucleotide-gated (HCN) channel, comprising (a) preparing the composition of claim 1 ; and (b) directly administering the composition of claim 12 to the mammalian heart.
3. The method of claim 2 , wherein the nucleic acid encoding at least one HCN channel encodes a HCN2 channel.
4. A method for inducing a pacemaker current in a subject's heart comprising: (a) preparing the composition of claim 1 ; and (b) administering the composition of claim 12 directly to the heart, wherein expression of the pacemaker ion channel in the mesenchymal stem cell generates a pacemaker current in the heart.
5. The method of claim 4 , wherein the nucleic acid encoding at least one HCN channel encodes a HCN2 channel.
6. The method of claim 4 , wherein the nucleic acid encodes a HCN1 channel.
7. An isolated mesenchymal stem cell transformed with a nucleic acid encoding at least one pacemaker ion channel, wherein the at least one pacemaker ion channel is a hyperpolarization-activated, cyclic nucleotide-gated (HCN) channel, and wherein the nucleic acid encoding the at least one pacemaker ion channel is expressed, wherein the mesenchymal stem cell further comprises a nucleic acid molecule encoding a MiRP1 polypeptide.
8. The mesenchymal stem cell of claim 7 , wherein the nucleic acid encoding at least one pacemaker ion channel encodes a HCN2 channel.
9. The composition of claim 1 , wherein the nucleic acid encoding at least one HCN channel encodes a HCN2 channel.
10. The mesenchymal stem cell of claim 7 , wherein the nucleic acid encoding at least one pacemaker ion channel encodes a HCN1 channel.
11. The composition of claim 1 , wherein the nucleic acid encoding at least one HCN channel encodes a HCN1 channel.
12. The method of claim 2 , wherein the nucleic acid encoding at least one HCN channel encodes a HCN1 channel.
13. The mesenchymal stem cell of claim 7 , wherein the nucleic acid encoding at least one pacemaker ion channel encodes a HCN4 channel.
14. The composition of claim 1 , wherein the nucleic acid encoding the at least one HCN channel encodes a HCN4 channel.
15. The method of claim 2 , wherein the nucleic acid encoding at least one HCN channel encodes a HCN4 channel.
16. The method of claim 4 , wherein the nucleic acid encodes a HCN4 channel.